Figure 4From: A randomized controlled phase IIb wound healing trial of cutaneous leishmaniasis ulcers with 0.045% pharmaceutical chlorite (DAC N-055) with and without bipolar high frequency electro-cauterization versus intralesional antimony in Afghanistan Wound closure time in ITT patients of Group I versus Group II versus Group III. Statistically significant difference between Group II versus Group I (p = 0.00004, Log-Rank [Mantel-Cox] test).Back to article page